- Optical Biology Core (OBC) The Optical Biology Core consists of a self-use facility (in McGaugh Hall) and a collaboration-based methods development facility located in the Beckman Laser Institute and Medical Clinic (BLIMC) namely, the Laser Microbeam and Medical Program facility (LAMMP), a NIBIB Biomedical Technology Resource Center. The self-use facility contains a Zeiss LSM 780 and a LSM 700 that can image living or fixed material. A two photon laser for deep tissue imaging and single photon lasers for imaging all fluorophores from DAPI (405nm) to far red (633nm) are available on the 780. A FLIM (Fluorescence Lifetime Microscopy) detector for studying molecules based on their fluorescence lifetime provides a way of studying any situation that would typically employ FRET. Dr. Syed manages this facility and provides training and on-site trouble shooting as well as experimental advice. Training is also provided for the Volocity image analysis software package that is available on a high end work station or from individual office computers. The web link is http://obc.bio.uci.edu. The second arm of the OBC includes the LAMMP facility. This NIBIB Biomedical Technology Resource Center is available for collaborative use and protocol development using a number of microscopes and technologies being developed by that center. Information about the capabilities can be found at http://lammp.bli.uci.edu/. These include Multi Dimensional Microscopy (MDM) platforms for studying skin carcinomas, techniques to detect early melanoma non-invasively, and breast cancer screening using visible light (diffuse optical spectroscopy and imaging, DOSI) rather than X-rays. Dr. Krasieva manages this facility and is available for consultation and protocol development for investigators seeking new imaging applications. They are supported by shop facilities that allow construction and modification of imaging platforms.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA062203-21
Application #
9416950
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
21
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Type
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92617
Chakraborty, Mahul; VanKuren, Nicholas W; Zhao, Roy et al. (2018) Hidden genetic variation shapes the structure of functional elements in Drosophila. Nat Genet 50:20-25
Morozko, Eva L; Ochaba, Joseph; Hernandez, Sarah J et al. (2018) Longitudinal Biochemical Assay Analysis of Mutant Huntingtin Exon 1 Protein in R6/2 Mice. J Huntingtons Dis 7:321-335
Carpenter, Philip M; Ziogas, Argyrios; Markham, Emma M et al. (2018) Laminin 332 expression and prognosis in breast cancer. Hum Pathol 82:289-296
Yan, Huaming; Romero-López, Mónica; Benitez, Lesly I et al. (2018) Multiscale modeling of glioblastoma. Transl Cancer Res 7:S96-S98
Yu, James; Landberg, Jenny; Shavarebi, Farbod et al. (2018) Bioengineering triacetic acid lactone production in Yarrowia lipolytica for pogostone synthesis. Biotechnol Bioeng 115:2383-2388
Oliver, Andrew; Kay, Matthew; Cooper, Kerry K (2018) Comparative genomics of cocci-shaped Sporosarcina strains with diverse spatial isolation. BMC Genomics 19:310
Mahlbacher, Grace; Curtis, Louis T; Lowengrub, John et al. (2018) Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment. J Immunother Cancer 6:10
Neek, Medea; Tucker, Jo Anne; Kim, Tae Il et al. (2018) Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses. Biomaterials 156:194-203
McLelland, Bryce T; Lin, Bin; Mathur, Anuradha et al. (2018) Transplanted hESC-Derived Retina Organoid Sheets Differentiate, Integrate, and Improve Visual Function in Retinal Degenerate Rats. Invest Ophthalmol Vis Sci 59:2586-2603
Bota, Daniela A; Chung, Jinah; Dandekar, Manisha et al. (2018) Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts. CNS Oncol 7:CNS22

Showing the most recent 10 out of 1106 publications